Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein
Cell Reports · 2023-03 · 42 (3) · 112142
DOI: 10.1016/j.celrep.2023.112142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-03. Verfasst von Jan Hellert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France; Centre for Structural …. Hauptthemen laut MEDLINE: Orthobunyavirus, La Crosse virus. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centre National de la Recherche Scientifique, Innovative Medicines Initiative, IMI.
Abstract (Originalsprache)
La Crosse virus, responsible for pediatric encephalitis in the United States, and Schmallenberg virus, a highly teratogenic veterinary virus in Europe, belong to the large Orthobunyavirus genus of zoonotic arthropod-borne pathogens distributed worldwide. Viruses in this under-studied genus cause CNS infections or fever with debilitating arthralgia/myalgia syndromes, with no effective treatment. The main surface antigen, glycoprotein Gc (∼1,000 residues), has a variable N-terminal half (GcS) targeted by the patients' antibody response and a conserved C-terminal moiety (GcF) responsible for membrane fusion during cell entry. Here, we report the X-ray structure of post-fusion La Crosse and Schmallenberg virus GcF, revealing the molecular determinants for hairpin formation and trimerization required to drive membrane fusion. We further experimentally confirm the role of residues in the fusion loops and in a vestigial endoplasmic reticulum (ER) translocation sequence at the GcS-GcF junction. The resulting knowledge provides essential molecular underpinnings for future development of potential therapeutic treatments and vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France; Centre for Structural Systems Biology (CSSB), Leibniz-Institut für Virologie (LIV), Notkestr…
- Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald, Germany; Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Südufer 10, 17493 G…
- Crystallography Platform C2RT, Institut Pasteur, CNRS UMR 3528, 25-28 rue du Dr. Roux, 75015 Paris, France.
- Structural Virology Unit, Institut Pasteur - Université Paris-Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France.
- Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald, Germany.
- Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, 17493 Greifswald, Germany. Electronic address: martin.beer@fli.de.
Förderung
- Centre National de la Recherche Scientifique
- Innovative Medicines Initiative
- IMI
- European Commission
- European Synchrotron Radiation Facility
- Institut Pasteur
Zitieren
APA
Hellert, J., Aebischer, A., Haouz, A., Guardado-Calvo, P., Reiche, S., Beer, M., & Rey, F. A. (2023). Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein. Cell Reports, 42(3), 112142. https://doi.org/10.1016/j.celrep.2023.112142
Vancouver
Hellert J, Aebischer A, Haouz A, Guardado-Calvo P, Reiche S, Beer M, et al. Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein. Cell Reports. 2023;42(3):112142. doi:10.1016/j.celrep.2023.112142
BibTeX
@article{Hellert2023,
author = {Hellert, Jan and Aebischer, Andrea and Haouz, Ahmed and Guardado-Calvo, Pablo and Reiche, Sven and Beer, Martin and Rey, Félix A},
title = {Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {3},
pages = {112142},
doi = {10.1016/j.celrep.2023.112142}
}
EUVIMED